Lianqin Li

983 total citations
34 papers, 754 citations indexed

About

Lianqin Li is a scholar working on Electrical and Electronic Engineering, Molecular Biology and Computer Networks and Communications. According to data from OpenAlex, Lianqin Li has authored 34 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Electrical and Electronic Engineering, 14 papers in Molecular Biology and 4 papers in Computer Networks and Communications. Recurrent topics in Lianqin Li's work include Advanced Fiber Optic Sensors (10 papers), Redox biology and oxidative stress (9 papers) and Glutathione Transferases and Polymorphisms (5 papers). Lianqin Li is often cited by papers focused on Advanced Fiber Optic Sensors (10 papers), Redox biology and oxidative stress (9 papers) and Glutathione Transferases and Polymorphisms (5 papers). Lianqin Li collaborates with scholars based in China, Japan and Canada. Lianqin Li's co-authors include Masuo Obinata, Wataru Shoji, Tomonori Kaifu, Toshiyuki Takai, Sataro Goto, Hirohisa Takano, Noriko Nishimura, Ryoya Takahashi, Yasunobu Aoki and Yinchuan Jin and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Lianqin Li

33 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianqin Li China 14 340 116 101 68 60 34 754
Keyi Zhang China 16 163 0.5× 204 1.8× 31 0.3× 90 1.3× 34 0.6× 86 840
Hailong Li China 16 219 0.6× 63 0.5× 34 0.3× 46 0.7× 10 0.2× 47 702
Wenxuan Li China 17 184 0.5× 213 1.8× 34 0.3× 99 1.5× 19 0.3× 70 906
Xiaoyu Zhu China 18 299 0.9× 61 0.5× 21 0.2× 34 0.5× 68 1.1× 61 936
Hai Zhang China 17 443 1.3× 177 1.5× 25 0.2× 38 0.6× 13 0.2× 33 1.0k
Guanqun Wang China 21 386 1.1× 21 0.2× 35 0.3× 45 0.7× 37 0.6× 79 1.1k
Guangjie Li China 24 373 1.1× 34 0.3× 59 0.6× 6 0.1× 81 1.4× 52 1.5k
Sharon S. Chen United States 11 616 1.8× 57 0.5× 18 0.2× 16 0.2× 38 0.6× 14 956
Yeqing Sun China 18 248 0.7× 93 0.8× 36 0.4× 85 1.3× 16 0.3× 73 1.1k
C. Gigliotti Italy 17 123 0.4× 201 1.7× 25 0.2× 55 0.8× 193 3.2× 42 1.0k

Countries citing papers authored by Lianqin Li

Since Specialization
Citations

This map shows the geographic impact of Lianqin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianqin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianqin Li more than expected).

Fields of papers citing papers by Lianqin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianqin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianqin Li. The network helps show where Lianqin Li may publish in the future.

Co-authorship network of co-authors of Lianqin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lianqin Li. A scholar is included among the top collaborators of Lianqin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianqin Li. Lianqin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Xiaoli, Junmei Hao, Xiangji Guo, et al.. (2024). Exploring the role of PRDX4 in the development of uterine corpus endometrial carcinoma. Medical Oncology. 41(2). 48–48. 3 indexed citations
2.
Wang, Hongmei, et al.. (2022). A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer. International Immunopharmacology. 108. 108743–108743. 18 indexed citations
3.
Wang, Zenghui, et al.. (2021). Fiber Core-Offset Humidity Sensor Based on Graphene Oxide Characteristics. IEEE photonics journal. 13(3). 1–8. 16 indexed citations
4.
Li, Lianqin, et al.. (2021). Micro-nano optical fiber coupled strain sensor. Optics and Precision Engineering. 29(5). 958–966.
5.
Yu, Hui, Junmei Hao, Xiaoyan Li, et al.. (2020). Decreased Expression of Peroxiredoxin in Patients with Ovarian Endometriosis Cysts. Archives of Medical Research. 51(7). 670–674. 4 indexed citations
6.
Li, Tiantian, et al.. (2019). Plasma level of peroxiredoxin 3 in patients with polycystic ovarian syndrome. BMC Endocrine Disorders. 19(1). 32–32. 2 indexed citations
7.
Li, Lianqin, Ke Zhang, Jian Jiao, et al.. (2019). Performance Analysis of Finite Length Non-Binary Raptor Codes under Ordered Statistics Decoder. 1–5. 3 indexed citations
8.
Zhang, Ke, Jian Jiao, Lianqin Li, et al.. (2019). Weight-Adaptive Analog Fountain Codes toward Massive Machine Type Communications. 1–5. 1 indexed citations
9.
Wang, Li, Junmei Hao, Tiantian Li, et al.. (2018). The association of plasma peroxiredoxin 3 with insulin in pregnant women. Biochemical and Biophysical Research Communications. 508(3). 805–810. 5 indexed citations
10.
Li, Lianqin, et al.. (2016). The Potential Role of Probiotics in Cancer Prevention and Treatment. Nutrition and Cancer. 68(4). 535–544. 90 indexed citations
11.
Li, Lianqin. (2016). The Relevance of Mammalian Peroxiredoxins to the Gametogenesis, Embryogenesis, and Pregnancy Outcomes. Reproductive Sciences. 24(6). 812–817. 5 indexed citations
12.
Li, Lianqin, Yonggang Zhang, Weiling Chen, et al.. (2015). HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells. Scientific Reports. 5(1). 7653–7653. 28 indexed citations
13.
Li, Lianqin, et al.. (2015). The functional role of peroxiredoxin 3 in reactive oxygen species, apoptosis, and chemoresistance of cancer cells. Journal of Cancer Research and Clinical Oncology. 141(12). 2071–2077. 24 indexed citations
14.
Li, Lianqin, Yonggang Zhang, & Chunling Chen. (2012). Anti‐apoptotic role of peroxiredoxin III in cervical cancer cells. FEBS Open Bio. 3(1). 51–54. 18 indexed citations
15.
Gao, Qun, et al.. (2012). Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancer. Biomedical Reports. 1(2). 228–230. 28 indexed citations
16.
Li, Lianqin, Masuo Obinata, & Katsuyoshi Hori. (2009). Role of Peroxiredoxin III in the Pathogenesis of Pre‐eclampsia as Evidenced in Mice. Oxidative Medicine and Cellular Longevity. 3(1). 71–73. 12 indexed citations
17.
Li, Lianqin, et al.. (2009). [Expression of peroxiredoxin III in cervical lesions].. PubMed. 23(6). 443–5. 3 indexed citations
18.
Wu, Laosheng, Pingping Jiang, Lianqin Li, et al.. (2008). Carbon Sequestration and Dynamics of Two Irrigated Agricultural Soils in California. Soil Science Society of America Journal. 72(3). 808–814. 62 indexed citations
19.
Li, Lianqin, et al.. (2008). Crucial role of peroxiredoxin III in placental antioxidant defense of mice. FEBS Letters. 582(16). 2431–2434. 40 indexed citations
20.
Li, Lianqin, Wataru Shoji, Hirohisa Takano, et al.. (2007). Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochemical and Biophysical Research Communications. 355(3). 715–721. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026